Adenosine Triphosphate Disodium Hydrate

三磷酸腺苷二钠水合物

Report date: 2023/02/09 09:31:50
NME

Base Information

Drug NameAdenosine Triphosphate Disodium Hydrate
Drug Alias NameAdenosine-5'-triphosphate三磷腺苷二钠三磷酸腺苷二钠盐Adenosine triphosphate disodium trihydrateAdenosine 5'-triphosphate disodium +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic P2 receptor agonists
TargetsPurinergic P2 receptor
Therapy Area/IndicationsSolid tumoursCachexiaHeart Failure +[9] 
Global Approved IndicationsHeart FailureMuscular AtrophyCerebral Hemorrhage +[4] 
Approved Indications in ChinaHeart FailureMuscular AtrophyCerebral Hemorrhage +[4] 
Original Approved Country/TerritoryJapan
Original Approved Date1961/07/01
Country/TerritoryCanadaUnited StatesNetherlands +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMcmaster UniversityChengdu Tongde Pharmaceutical Co LtdAstellas Pharmaceutical Technology Co Ltd
Inactive CompaniesUtah State UniversityMaastricht University Medical CenterNational Cancer Institute
Active IndicationsHeart FailureMuscular AtrophyCerebral Hemorrhage +[6] 
Inactive IndicationsSolid tumoursCachexiaNeoplasms

Other Information

ATC CodeC01EB10
Related LinksWikipediaDrugBankKEGG